Anhui Fengyuan Pharmaceutical Co., Ltd. announced earnings results for the nine months ended September 30, 2019. For the nine months, the company announced sales was CNY 2,385.572 million compared to CNY 2,231.218 million a year ago. Operating income was CNY 106.030 million compared to CNY 86.326 million a year ago. Net income was CNY 75.142 million compared to CNY 56.435 million a year ago. Basic earnings per share from continuing operations was CNY 0.2407 compared to CNY 0.178 a year ago.